Chitosan hydrogels containing liposomes and cubosomes as particulate sustained release vaccine delivery systems

References

• Bangham, A. D., Standish, M. M., Watkins, J. C. (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252.
   PubMed Web of Science ®Google Scholar
• Barnden, M. J., Allison, J., Heath, W. R., Carbone, F. R. (1998). Defective TCR expression in transgenic mice constructed using cDNA-based a- and b-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol 76:34–40.
   PubMed Web of Science ®Google Scholar
• Bramwell, V. W., Perrie, Y. (2005). Particulate delivery systems for vaccines. Crit Rev Ther Drug Carrier Syst 22:151–214.
   PubMed Web of Science ®Google Scholar
• Brgles, M., Jurašin, D., Sikirić, M. D., Frkanec, R., Tomašić, J. (2008). Entrapment of ovalbumin into liposomes—factors affecting entrapment efficiency, liposome size, and zeta potential. J Liposome Res 18:235–248.
   PubMed Web of Science ®Google Scholar
• Casals, E., Soler, M., Gallardo, M., Estelrich, J. (1998). Electrophoretic behavior of stearylamine-containing liposomes. Langmuir 14:7522–7526.
   Web of Science ®Google Scholar
• Chenite, A., Buschmann, M., Wang, D., Chaput, C., Kandani, N. (2001). Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions. Carbohydr Polym 46:39–47.
   Web of Science ®Google Scholar
• Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M. D., Hoemann, C. D., et al. (2000). Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21:2155–2161.
   PubMed Web of Science ®Google Scholar
• Chikh, G., Schutze-Redelmeir, M.-P. (2002). Liposomal delivery of CTL epitopes to dendritic cells. Biosci Rep 22:339–353.
   PubMed Web of Science ®Google Scholar
• Cho, J., Heuzey, M.-C., Begin, A., Carreau, P. J. (2005). Physical gelation of chitosan in the presence of ß-glycerophosphate: the effect of temperature. Biomacromolecules 6:3267–3275.
   PubMed Web of Science ®Google Scholar
• Copland, M. J., Baird, M. A., Rades, T., McKenzie, J. L., Becker, B., Reck, F., et al. (2003). Liposomal delivery of antigen to human dendritic cells. Vaccine 21:883–890.
   PubMed Web of Science ®Google Scholar
• Demana, P. H., Fehske, C., White, K., Rades, T., Hook, S. (2004). Effect of incorporation of the adjuvant Quil A on structure and immune stimulatory capacity of liposomes. Immunol Cell Biol 82:547–554.
   PubMed Web of Science ®Google Scholar
• Dong, Y.-D., Larson, I., Hanley, T., Boyd, B. J. (2006). Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure. Langmuir 22:9512–9518.
   PubMed Web of Science ®Google Scholar
• Ellis, R. W. (2001). Technologies for the design, discovery, formulation, and administration of vaccines. Vaccine 19:2681–2687.
   PubMed Web of Science ®Google Scholar
• Foged, C., Arigita, C., Sundblad, A., Jiskoot, W., Storm, G., Frokjaer, S. (2004). Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine 22:1903–1913.
   PubMed Web of Science ®Google Scholar
• Foged, C., Brodin, B., Frokjaer, S., Sundblad, A. (2005). Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. Int J Pharm 298:315–322.
   PubMed Web of Science ®Google Scholar
• Gamvrellis, A., Leong, D., Hanley, J. C., Xiang, S. D., Mottram, P., Plebanski, M. (2004). Vaccines that facilitate antigen entry into dendritic cells. Immunol Cell Biol 82:506–516.
   PubMed Web of Science ®Google Scholar
• Gasparri, J., Speroni, L., Chiaramoni, N. S., Valle Alonso, S. D. (2011). Relationship between the adjuvant and cytotoxic effects of the positive charges and polymerization in liposomes. J Liposome Res 21:124–133.
   PubMed Web of Science ®Google Scholar
• Gordon, S., Saupe, A., McBurney, W., Rades, T., Hook, S. (2008). Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery. J Pharm Pharmacol 60:1591–1600.
   PubMed Web of Science ®Google Scholar
• Gregoriadis, G. (1990). Immunological adjuvants: a role for liposomes. Immunol Today 11:89–97.
   PubMedGoogle Scholar
• Gupta, R. K. (1998). Aluminum compounds as vaccine adjuvants. Adv Drug Delivery Rev 32:155–172.
   PubMed Web of Science ®Google Scholar
• Han, I.-K., Kim, Y. B., Kang, H.-S., Sul, D., Jung, W.-W., Cho, H. J., et al. (2006). Thermosensitive and mucoadhesive delivery systems of mucosal vaccines. Methods 38:106–111.
   PubMed Web of Science ®Google Scholar
• Hecht, T. T., Longo, D. L., Matis, L. A. (1983). The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones. J Immunol 131:1049–1055.
   PubMed Web of Science ®Google Scholar
• Heeg, K., Kuon, W., Wagner, H. (1991). Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide. Eur J Immunol 21:1523–1527.
   PubMed Web of Science ®Google Scholar
• Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., Carbone, F. R. (1994). T cell receptor antagonist peptides induce positive selection. Cell 76:17–27.
   PubMed Web of Science ®Google Scholar
• Kamath, A. T., Pooley, J., O’Keeffe, M. A., Vremec, D., Zhan, Y., Lew, A. M., et al. (2000). The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 165:6762–6770.
   PubMedGoogle Scholar
• Kenney, R. T., Edelman, R. (2003). Survey of human-use adjuvants. Expert Rev Vaccines 2:167–188.
   PubMedGoogle Scholar
• Kensil, C. R. (1996). Saponins as vaccine adjuvants. Crit Rev Ther Drug Carrier Syst 13:1–55.
   PubMed Web of Science ®Google Scholar
• Kersten, G. F. A., Crommelin, D. J. A. (2003). Liposomes and ISCOMs. Vaccine 21:915–920.
   PubMed Web of Science ®Google Scholar
• Könnings, S., Copland, M. J., Davies, N. M., Rades, T. (2002). A method for the incorporation of ovalbumin into immune stimulating complexes prepared by the hydration method. Int J Pharm 241:385–389.
   PubMed Web of Science ®Google Scholar
• Li, H., Willingham, S. B., Ting, J. P.-Y., Re, F. (2008). Cutting edge: inflammasome activation by alum and alum’s adjuvant effect are mediated by NLRP3. J Immunol 181:17–21.
   PubMed Web of Science ®Google Scholar
• Lipford, G. B., Wagner, H., Heeg, K. (1994). Vaccination with immunodominant peptides encapsulated in Quil A-containing liposomes induces peptide-specific primary CD8+ cytotoxic T cells. Vaccine 12:73–80.
   PubMed Web of Science ®Google Scholar
• Lofthouse, S. (2002). Immunological aspects of controlled antigen delivery. Adv Drug Deliv Rev 54:863–870.
   PubMed Web of Science ®Google Scholar
• Lonez, C., Vandenbranden, M., Ruysschaert, J.-M. (2008). Cationic liposomal lipids: from gene carriers to cell signaling. Prog Lipid Res 47:340–347.
   PubMed Web of Science ®Google Scholar
• Macatonia, S. E., Doherty, T. M., Knight, S. C., O’Garra, A. (1993). Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J Immunol 150:3755–3765.
   PubMedGoogle Scholar
• McBurney, W. T., Lendemans, D. G., Myschik, J., Hennessy, T., Rades, T., Hook, S. (2008). In vivo activity of cationic immune stimulating complexes (PLUSCOMs). Vaccine 26:4549–4556.
   PubMed Web of Science ®Google Scholar
• Myschik, J., McBurney, W. T., Hennessy, T., Phipps-Green, A., Rades, T., Hook, S. (2008). Immunostimulatory biodegradable implants containing the adjuvant Quil-A. Part II: in vivo evaluation. J Drug Target 16:224–232.
   PubMed Web of Science ®Google Scholar
• Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y., Kubo, K., Nakagawa, S., et al. (1997). Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem Biophys Res Commun 240:793–797.
   PubMed Web of Science ®Google Scholar
• Nakanishi, T., Kunisawa, J., Hayashi, A., Tsutsumi, Y., Kubo, K., Nakagawa, S., et al. (1999). Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J Control Release 61:233–240.
   PubMed Web of Science ®Google Scholar
• O’Hagan, D. T. (2001). Recent developments in vaccine delivery systems. Curr Drug Targets Infect Disord 1:273–286.
   PubMedGoogle Scholar
• Peek, L. J., Middaugh, C. R., Berkland, C. (2008). Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:915–928.
   PubMed Web of Science ®Google Scholar
• Perrie, Y., Mohammed, A. R., Kirby, D. J., McNeil, S. E., Bramwell, V. W. (2008). Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens. Int J Pharm 364:272–280.
   PubMed Web of Science ®Google Scholar
• Rao, M., Alving, C. R. (2000). Delivery of lipids and liposomal proteins to the cytoplasm and golgi of antigen-presenting cells. Adv Drug Deliv Rev 41:171–188.
   PubMed Web of Science ®Google Scholar
• Rizwan, S. B., Assmus, D., Boehnke, A., Hanley, T., Boyd, B. J., Rades, T., et al. (2011). Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines. Eur J Pharm Biopharm 79:15–22.
   PubMed Web of Science ®Google Scholar
• Rizwan, S. B., Dong, Y. D., Boyd, B. J., Rades, T., Hook, S. (2007). Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron 38:478–485.
   PubMed Web of Science ®Google Scholar
• Rizwan, S. B., Hanley, T., Boyd, B. J., Rades, T., Hook, S. (2009). Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: characterisation, swelling, and release kinetics. J Pharm Sci 98:4191–4204.
   PubMed Web of Science ®Google Scholar
• Ruel-Gariépy, E., Chenite, A., Chaput, C., Guirguis, S., Leroux, J.-C. (2000). Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 203:89–98.
   PubMed Web of Science ®Google Scholar
• Senior, J. H., Trimble, K. R., Maskiewicz, R. (1991). Interaction of positively-charged liposomes with blood: implications for their application in vivo. Biochim Biophys Acta 1070:173–179.
   PubMed Web of Science ®Google Scholar
• Sjölander, A., van’t Land, B., Bengtsson, K. L. (1997). ISCOMs containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses. Cell Immunol 177:69–76.
   PubMed Web of Science ®Google Scholar
• Soltysik, S., Wu, J.-Y., Recchia, J., Wheeler, D. A., Newman, M. J., Coughlin, R. T., et al. (1995). Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 13:1403–1410.
   PubMed Web of Science ®Google Scholar
• Spicer, P. T. (2005). Progress in liquid crystalline dispersions: cubosomes. Curr Opin Coll Interf Sci 10:274–279.
   Web of Science ®Google Scholar
• Storni, T., Kündig, T. M., Senti, G., Johansen, P. (2005). Immunity in response to particulate antigen-delivery systems. Adv Drug Deliv Rev 57:333–355.
   PubMed Web of Science ®Google Scholar
• Tao Liang, M., Davies, N. M., Blanchfield, J. T., Toth, I. (2006). Particulate systems as adjuvants and carriers for peptide and protein antigens. Curr Drug Deliv 3:379–388.
   PubMedGoogle Scholar
• Upham, J. W., Strickland, D. H., Robinson, B. W., Holt, P. G. (1997). Selective inhibition of T cell proliferation but not expression of effector function by human alveolar macrophages. Thorax 52:786–795.
   PubMedGoogle Scholar
• Vangala, A., Bramwell, V. W., McNeil, S., Christensen, D., Agger, E. M., Perrie, Y. (2007). Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. J Control Release 119:102–110.
   PubMed Web of Science ®Google Scholar
• Vangasseri, D. P., Cui, Z., Chen, W., Hokey, D. A., Falo, L. D., Huang, L. (2006). Immunostimulation of dendritic cells by cationic liposomes. Mol Membr Biol 23:385–395.
   PubMed Web of Science ®Google Scholar
• White, K., Rades, T., Kearns, P., Toth, I., Hook, S. (2006). Immunogenicity of liposomes containing lipid core peptides and the adjuvant Quil A. Pharm Res 23:1473–1481.
   PubMed Web of Science ®Google Scholar
• Yaghmur, A., Glatter, O. (2009). Characterization and potential applications of nanostructured aqueous dispersions. Adv Coll Interf Sci 147–148:333–342.
   PubMed Web of Science ®Google Scholar
• Zaharoff, D. A., Rogers, C. J., Hance, K. W., Schlom, J., Greiner, J. W. (2007). Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination. Vaccine, 25:2085–2094.
   PubMed Web of Science ®Google Scholar
• Zhao, Z., Leong, K. W. (1996). Controlled delivery of antigens and adjuvants in vaccine development. J Pharm Sci 85:1261–1270.
   PubMed Web of Science ®Google Scholar
• Zinkernagel, R. M., Ehl, S., Aichele, P., Oehen, S., Kündig, T., Hengartner, H. (1997). Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 156:199–209.
   PubMed Web of Science ®Google Scholar